The RNA modification N6-methyladenosine restrains SIRPα to license myeloid efferocytosis in atherosclerosis
Aneesh S. Kallapur, Xiang Li, Elena Rodríguez‐Sánchez, Zhengyi Zhang, Aniketa Sinha, Lijing Cheng, Dan Wang, Jing Gu, Jason Kim, Xiaohui Wu, Wei Li, Ya Cui, Xin He, Chuan He, Tamer Sallam
This study identifies the m6A-SIRP axis as a regulator of efferocytosis in atherosclerosis, showing myeloid m6A loss increases plaque instability.
bioRxiv · Sep 21, 2026 · PreprintPhysiology